Please check your internet connection and try again.
# Walethmade Bromide
## Overview
Walethmade bromide is a synthetic anticholinergic agent.
## Primary Indications
Primarily used for the symptomatic treatment of tremor, particularly in Parkinson's disease and drug-induced extrapyramidal symptoms. Also used for the management of hypersalivation.
## Adult Dosing
* **Tremor (Parkinson's Disease):** Start with 5 mg to 10 mg orally once daily. Gradually increase dose as tolerated up to a maximum of 30 mg per day, divided into 2-3 doses.
* **Drug-Induced Extrapyramidal Symptoms:** Start with 5 mg to 10 mg orally once to three times daily. Adjust dose based on patient response and tolerability, not to exceed 30 mg per day.
* **Hypersalivation:** Typical dose is 5 mg to 10 mg orally once to three times daily. Dosing is highly individualized.
## Pediatric Dosing
Safety and efficacy in pediatric patients have not been established. Use is not recommended.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; no specific dose adjustments are routinely recommended, but starting at the lower end of the dosing range and titrating slowly is advised.
* **Renal Impairment:** Use with caution; no specific dose adjustments are routinely recommended, but starting at the lower end of the dosing range and titrating slowly is advised.
* **Elderly:** May be more sensitive to anticholinergic effects. Start at lower doses and titrate cautiously.
## Contraindications
* Known hypersensitivity to walethmade bromide or any component of the formulation.
* Conditions where anticholinergic effects are detrimental, such as narrow-angle glaucoma, myasthenia gravis, paralytic ileus, toxic megacolon, uncontrolled heart rhythm disorders, prostatic hypertrophy with urinary retention, and pyloric stenosis.
## Adverse Effects
Common anticholinergic effects: dry mouth, blurred vision, constipation, urinary retention, drowsiness, confusion, dizziness, tachycardia. Less common: hallucinations, memory impairment, photophobia, increased heart rate, difficulty urinating.
## Key Drug Interactions
* **Other Anticholinergics:** Increased risk of anticholinergic side effects.
* **CNS Depressants (e.g., sedatives, hypnotics, benzodiazepines, alcohol):** Additive CNS depression.
* **Potassium Chloride:** Risk of gastrointestinal ulceration, bleeding, or perforation when used in high doses.
* **Dopaminergic Agents (e.g., Levodopa):** May decrease the absorption of levodopa.
* **Amantadine:** Increased anticholinergic and CNS side effects.
## Monitoring
* Monitor for therapeutic response (reduction in tremor or hypersalivation).
* Monitor for adverse anticholinergic effects (dry mouth, constipation, urinary retention, blurred vision, cognitive changes, dizziness).
* Assess for signs of gastrointestinal obstruction or urinary retention.
* For patients with cardiac history, monitor heart rate and rhythm.
## Clinical Pearls
* Administer with food or milk to minimize gastrointestinal upset.
* Gradual dose titration is crucial to minimize adverse effects.
* Patients should be advised about potential drowsiness and to avoid driving or operating heavy machinery until they know how the medication affects them.
* Encourage adequate fluid intake and fiber to mitigate constipation.
* Consider dental hygiene measures to prevent cavities due to dry mouth.
* Abrupt discontinuation may lead to rebound symptoms.
***
*This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions. Dosing may vary based on individual patient factors, local protocols, and specific product formulations.*
